Clinical Trial Update: Phase III Study in Refractory Behcet's Disease [Phase 3]

View source ↗

Summary

Phase III trial in refractory Behcet's disease completed; results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Behcet Disease

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Behcet Disease | Phase 3 | Status: COMPLETED | Results posted: 2015-08-31